Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Ford

Showing results (211-220 of 508) with videos related to

Pageof 51
Sort By:
Trials|May 1, 2015
Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchersJonathan A Cook, Jenni Hislop, Douglas G Altman, et al.
Circulation|February 23, 2017
Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention SettingPradeep Natarajan, Robin Young, Nathan O Stitziel, et al.
European Heart Journal|June 7, 2014
The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trialsStefan D Anker, Stefan Agewall, Martin Borggrefe, et al.
Lancet (London, England)|September 29, 2015
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trialBryan Williams, Thomas M MacDonald, Steve Morant, et al.
Frontiers in Neurology|December 12, 2019
Current Smoking Does Not Modify the Treatment Effect of Intravenous Thrombolysis in Acute Ischemic Stroke Patients-A <i>Post-hoc</i> Analysis of the WAKE-UP TrialLudwig Schlemm, Anna Kufner, Florent Boutitie, et al.
European Journal of Preventive Cardiology|February 18, 2016
High-sensitivity cardiac troponin T is associated with cognitive decline in older adults at high cardiovascular riskLiselotte W Wijsman, Anton Jm de Craen, Stella Trompet, et al.
Plos Medicine|January 27, 2009
Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysisIan Ford, Vladimir Bezlyak, David J Stott, et al.
European Stroke Journal|September 19, 2025
Randomised, controlled Trial of CT perfusion and angiography compared to CT alone in thrombolysis-eligible acute ischaemic stroke patients: The penumbra and recanalisation acute computed tomography in ischaemic stroke evaluation (PRACTISE) trialKeith W Muir, Salwa El Tawil, Alex McConnachie, et al.
Diabetologia|September 30, 2014
Contrasting associations of insulin resistance with diabetes, cardiovascular disease and all-cause mortality in the elderly: PROSPER long-term follow-upPaul Welsh, David Preiss, Suzanne M Lloyd, et al.
Journal of the American Heart Association|November 7, 2012
Microvascular Resistance Predicts Myocardial Salvage and Infarct Characteristics in ST-Elevation Myocardial InfarctionAlexander R Payne, Colin Berry, Orla Doolin, et al.
Pageof 51

Showing results (211-220 of 508) with videos related to

Sort By:
Pageof 51
Trials|May 1, 2015
Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchersJonathan A Cook, Jenni Hislop, Douglas G Altman, et al.
Circulation|February 23, 2017
Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention SettingPradeep Natarajan, Robin Young, Nathan O Stitziel, et al.
European Heart Journal|June 7, 2014
The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trialsStefan D Anker, Stefan Agewall, Martin Borggrefe, et al.
Lancet (London, England)|September 29, 2015
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trialBryan Williams, Thomas M MacDonald, Steve Morant, et al.
Frontiers in Neurology|December 12, 2019
Current Smoking Does Not Modify the Treatment Effect of Intravenous Thrombolysis in Acute Ischemic Stroke Patients-A <i>Post-hoc</i> Analysis of the WAKE-UP TrialLudwig Schlemm, Anna Kufner, Florent Boutitie, et al.
European Journal of Preventive Cardiology|February 18, 2016
High-sensitivity cardiac troponin T is associated with cognitive decline in older adults at high cardiovascular riskLiselotte W Wijsman, Anton Jm de Craen, Stella Trompet, et al.
Plos Medicine|January 27, 2009
Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysisIan Ford, Vladimir Bezlyak, David J Stott, et al.
European Stroke Journal|September 19, 2025
Randomised, controlled Trial of CT perfusion and angiography compared to CT alone in thrombolysis-eligible acute ischaemic stroke patients: The penumbra and recanalisation acute computed tomography in ischaemic stroke evaluation (PRACTISE) trialKeith W Muir, Salwa El Tawil, Alex McConnachie, et al.
Diabetologia|September 30, 2014
Contrasting associations of insulin resistance with diabetes, cardiovascular disease and all-cause mortality in the elderly: PROSPER long-term follow-upPaul Welsh, David Preiss, Suzanne M Lloyd, et al.
Journal of the American Heart Association|November 7, 2012
Microvascular Resistance Predicts Myocardial Salvage and Infarct Characteristics in ST-Elevation Myocardial InfarctionAlexander R Payne, Colin Berry, Orla Doolin, et al.
Pageof 51